Rigel Pharma (RIGL) Tops Q1 EPS by 63c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $38.70 +3.39%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
SGHC, GTE, FIRY, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
SGHC, GTE, FIRY, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of $0.63. Revenue for the quarter came in at $53.33 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amprius Technologies, Inc. (AMPX) Reports In-Line Q1 EPS; offers guidance
- Morgan Stanley Upgrades Humana (HUM) to Equalweight
- Morgan Stanley Upgrades Grupo Aeroportuario del Pacifico (PAC) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
